Pfizer to offer cheaper US drugs via Trump\s website in new deal

US President Donald Trump shakes hands with Pfizer CEO Albert Bourla, on the day he announces a deal to sell drugs at lower prices

In a statement on Tuesday, Pfizer said the majority of its primary care drugs would be available on TrumpRx, but did not disclose specific medicines.

The company also said it would invest an additional $70bn (£52bn) in US manufacturing, research and development.

Pfizer‘s agreement is the latest example of concessions from pharmaceutical companies to avoid Trump’s tariffs on branded drugs for three years.

Albert Bourla, Pfizers chief executive, said: We now have the certainty and stability we need on two critical fronts, tariffs and pricing.

Pfizer shares rose nearly 7% on Tuesday following the announcement.

Trump conceded that drug prices may rise abroad because of his actions aimed at lowering prices in the US.

Eli Lilly, for example, has said it will raise drug prices in Europe in order to make them lower in the US.

It is unclear whether Trumps push including the direct-to-consumer website, which is expected to launch early 2026, will actually bring down prices for American consumers, since insurance companies and other middlemen also influence costs.